Related Experiment Video
Updated: Sep 21, 2025

07:36
Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
15.7K
Sildenafil-Induced Revascularization of Rat Hindlimb Involves Arteriogenesis through PI3K/AKT and eNOS Activation
Celine Baron-Menguy1,2, Arnaud Bocquet1, Alexis Richard1
1MITOVASC, Equipe CarMe, CNRS 6015, Inserm 1083, Angers Université, 49100 Angers, France.
International Journal of Molecular Sciences
|May 28, 2022
Summary
Sildenafil enhances blood flow and blood vessel growth after ischemia, independent of VEGF. This occurs through activation of PI3-kinase, Akt, and eNOS pathways, promoting arteriogenesis.
Area of Science:
- Vascular Biology
- Pharmacology
- Ischemia Research
Background:
- Hypoxia and inflammation are key factors in revascularization after ischemia.
- Sildenafil's mechanism for inducing revascularization, despite inhibiting phosphodiesterase-5 and increasing cGMP, is not fully understood.
Purpose of the Study:
- To investigate the effects of sildenafil on post-ischemic revascularization.
- To elucidate the molecular pathways involved in sildenafil-mediated revascularization.
Main Methods:
- Rats underwent femoral artery ligation, with some receiving sildenafil (25 mg/kg/day).
- Vascular density, blood flow, and arteriolar density were assessed.
- Expression of HIF-1α, VEGF, PI3-kinase, Akt, and eNOS was analyzed.
- Effects of anti-VEGF antibodies were evaluated.
Main Results:
- Sildenafil significantly increased vascular density and blood flow in ischemic limbs compared to controls.
- Sildenafil treatment did not alter VEGF or HIF-1α expression, suggesting angiogenesis independence.
- PI3-kinase, Akt, and eNOS activation was observed with sildenafil, linked to outward arterial remodeling (arteriogenesis).
Conclusions:
- Sildenafil promotes tissue blood flow and arteriogenesis post-ischemia.
- These effects are independent of the VEGF pathway.
- Sildenafil's action involves the PI3-kinase/Akt/eNOS signaling cascade.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
256
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
256
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Mechanism of Angiogenesis
6.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K

